NMCC Clinical Trials: Suspended / Active, NOT Recruiting / Terminated

CLINICAL TRIALS MENU

The listing below of clinical trials in use by New Mexico Cancer Center is primarily intended for medical and radiation oncologists, nurses and clinical trial coordinators. If you are a patient, we encourage you to discuss with your oncologist whether there are any clinical trials that might be of benefit to you. Unless otherwise noted, the information below, including Trial Status, Date Opened and Date Updated, is obtained from ClinicalTrials.gov. Complete detailed information including eligibility criteria for each trial is available by clicking the ClinicalTrials.gov link provided in that trial's Description Box.

Category Trial ID Org Description
Official Title / (Optional) Comment / ClinicalTrials.gov link
Trial Status Opened


Updated
Blood S1612 NMCCA

A Randomized Phase II/III Trial of “Novel Therapeutics” Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial


CinicalTrials.govDetails and eligibility criteria
Suspended 22 Dec 2017


16 Nov 2018
Breast Advanced Novartis CLEE011A2404 NMCCA

COMPLEEMENT-1: An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease


CinicalTrials.govDetails and eligibility criteria
Active, NOT Recruiting 21 Jun 2016


16 Nov 2018
GI Pancreatic Advanced SWOG S1513 NMCCA

Randomized Phase II Study of 2nd Line FOLFIRI versus Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer


CinicalTrials.govDetails and eligibility criteria
Active, NOT Recruiting 7 Sep 2016


2 Nov 2018
GU Prostate Advanced NRG-GU003 NMCCA

A Randomized Phase III Trial of Hypofractionated Post-prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-prostatectomy Radiation Therapy (COPORT)


CinicalTrials.govDetails and eligibility criteria
Active, NOT Recruiting 7 Sep 2017


14 Aug 2018
GU Prostate Metastatic BAY 1841788 / 17777 PCR

A Randomized, Double-blind, Placebo Controlled Phase III Study of Darolutamide (ODM-201) Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients With Metastatic Hormone Sensitive Prostate Cancer


CinicalTrials.govDetails and eligibility criteria
Active, NOT Recruiting 15 Jun 2016


24 Oct 2018
Head And Neck Adjuvant RTOG 1216 NMCCA

Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck


CinicalTrials.govDetails and eligibility criteria
Active, NOT Recruiting 14 Mar 2014


31 Aug 2018
Hematology – See: Blood
Leukemia – SEE: blood
Lung SCLC Advanced RTOG 1306 NMCCA

A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)


CinicalTrials.govDetails and eligibility criteria
Terminated 2 Apr 2013


15 Oct 2018
Pancreatic – SEE: GI Pancreatic
Prostate (all stages) – SEE: GU Prostate
Skin Melanoma Advanced ECOG-ACRIN EA6141 NMCCA

Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma


Unable to find this clinical trial listed on ClinicalTrials.gov
Suspended 21 Mar 2017


17 Nov 2018
TRIAL STATS: Suspended, Active NOT Recruiting / Terminated. Total = 8

Your Strongest Ally to Conquer Cancer

Pin It on Pinterest